Clinical success of LOW LEVEL LASER THERAPY to treat FMS reported in Fibromyalgia Aware

Apr 20 2010

Fibromyalgia is a condition in which the brain processes pain in an abnormal way, resulting in chronic, widespread muscular-skeletal pain and chronic fatigue. This condition effects millions of Americans and has been poorly understood and under diagnosed, resulting in billions of dollars in cost to our health care system. In the past, treatments have been primarily with medications; often side effects can make the symptoms worse.

The Laser is the Patented ML830 which was the first "LOW LEVEL LASER" approved by the FDA in 2002 to treat pain and swelling. The Laser produces no heat to the tissue and causes vassal dilation in the Micro Capillary bed, the treatment is PAINLESS WITH NO SIDE EFFECTS. Bernard Filner M.D. is now reporting on treating over 90,000 Fibro Trigger Points using the ML830 Laser with a 90% success rate.

Bernard Filner, M.D. reports his clinical success in the use of LOW LEVEL LASER THERAPY to treat FIBROMYALGIA SYNDROME (FMS) in the April 2010 issue of Fibromyalgia Aware (the quarterly journal of the National Fibromyalgia Association) Dr. Filner sits on the National Advisory Board. Dr. Filner has been in the forefront of the practice of Pain Management for the past 22 years, (specializing in the treatment of MYOFASCIAL PAIN and FIBROMYALGIA) and an anesthesiologist for the prior 18 years (CV available upon request).